[S22-02] Early detection of vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic acidaemia) in extended newborn screening (ENS)

Last updated 11.03.2024

Project no.:
S22-02

Commission:
Commission awarded on 25.11.2022 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Non-Drug Interventions

Application field:
Children's and adolescents' health

DOI:

https://dx.doi.org/10.60584/S22-02

Final report: Early detection of vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic acidaemia) in extended newborn screening (ENS)

DOI:

https://dx.doi.org/10.60584/S22-02

DE, PDF, 1 MB, PDF

published on Mar 11, 2024
Documentation of comments on the preliminary report: Early detection of vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic acidaemia) in extended newborn screening (ENS)

DE, PDF, 2 MB, PDF

published on Mar 11, 2024
Preliminary report: Early detection of vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic acidaemia) in extended newborn screening (ENS)

DE, PDF, 870 kB, PDF

published on Sep 6, 2023
Report plan: Early detection of vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic acidaemia) in extended newborn screening (ENS)

DE, PDF, 457 kB, PDF

published on Mar 21, 2023

Contact

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.